Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| Yesterday 12:02 PM View:  | Hemispherx Biopharma, Inc. (AIM) | 20-Nov-24 | Private Purchase | 81,953 | $0.19 | $15,816.90 | 34% 239.8K to 321.75K | |
| 18-Mar-24 3:01 PM View: | Hemispherx Biopharma, Inc. (AIM) | 15-Mar-24 | Private Purchase | 90,910 | $0.33 | $30,000.30 | 61% 148.85K to 239.76K | |
| 10-Mar-23 4:05 PM View: | Hemispherx Biopharma, Inc. (AIM) | 10-Mar-23 | Disposition (other) | 68,208 | $1.23 | $83,895.80 | (31%) 217.06K to 148.85K | |
| 04-Jan-23 7:30 AM View: | Hemispherx Biopharma, Inc. (AIM) | 03-Jan-23 | Private Purchase | 80,646 | $0.31 | $25,000.30 | 59% 136.42K to 217.06K | |
| 27-Apr-22 3:46 PM View: | Hemispherx Biopharma, Inc. (AIM) | 25-Apr-22 | Grant | 24,500 | $1.07 | $26,215.00 | 22% 111.92K to 136.42K | |
| 24-Nov-21 1:57 PM View: | Hemispherx Biopharma, Inc. (AIM) | 24-Nov-21 | Grant | 19,379 | $1.29 | $24,998.90 | 21% 92.54K to 111.92K | 6% |
| 25-Feb-21 3:07 PM View: | Hemispherx Biopharma, Inc. (AIM) | 25-Feb-21 | Market Purchase | 10,638 | $2.35 | $24,999.30 | 13% 81.9K to 92.54K | (50%) |
| 16-Dec-19 1:28 PM View: | Hemispherx Biopharma, Inc. (AIM) | 13-Dec-19 | Acquisition (other) | 8,358 | $0.45 | $3,801.22 | 11% 72.97K to 81.33K | 137% |
| 02-Dec-19 12:57 PM View: | Hemispherx Biopharma, Inc. (AIM) | 29-Nov-19 | Acquisition (other) | 9,503 | $0.40 | $3,801.20 | 15% 63.47K to 72.97K | 200% |
| 18-Nov-19 4:22 PM View: | Hemispherx Biopharma, Inc. (AIM) | 15-Nov-19 | Acquisition (other) | 8,264 | $0.46 | $3,801.44 | 15% 55.2K to 63.47K | 200% |
| 01-Nov-19 11:16 AM View: | Hemispherx Biopharma, Inc. (AIM) | 31-Oct-19 | Acquisition (other) | 7,603 | $0.50 | $3,801.50 | 16% 47.6K to 55.2K | 140% |
| 17-Oct-19 4:57 PM View: | Hemispherx Biopharma, Inc. (AIM) | 17-Oct-19 | Acquisition (other) | 6,911 | $0.55 | $3,801.05 | 17% 40.69K to 47.6K | 107% |
| 04-Oct-19 12:43 PM View: | Hemispherx Biopharma, Inc. (AIM) | 02-Oct-19 | Acquisition (other) | 5,002 | $0.76 | $3,801.52 | 14% 35.69K to 40.69K | 66% |
| 18-Sep-19 2:00 PM View: | Hemispherx Biopharma, Inc. (AIM) | 16-Sep-19 | Acquisition (other) | 2,033 | $1.87 | $3,801.71 | 6% 33.65K to 35.69K | (38%) |
| 05-Sep-19 1:36 PM View: | Hemispherx Biopharma, Inc. (AIM) | 03-Sep-19 | Acquisition (other) | 2,112 | $1.80 | $3,801.60 | 7% 31.54K to 33.65K | (34%) |
| 20-Aug-19 11:20 AM View: | Hemispherx Biopharma, Inc. (AIM) | 16-Aug-19 | Acquisition (other) | 2,001 | $1.90 | $3,801.90 | 7% 29.54K to 31.54K | (37%) |
| 02-Aug-19 12:33 PM View: | Hemispherx Biopharma, Inc. (AIM) | 31-Jul-19 | Acquisition (other) | 1,618 | $2.35 | $3,802.30 | 6% 27.92K to 29.54K | (50%) |
| 18-Jul-19 12:58 PM View: | Hemispherx Biopharma, Inc. (AIM) | 16-Jul-19 | Acquisition (other) | 920 | $4.13 | $3,799.60 | 3% 27.57K to 28.49K | (72%) |
| 08-Jul-19 2:11 PM View: | Hemispherx Biopharma, Inc. (AIM) | 03-Jul-19 | Acquisition (other) | 866 | $4.39 | $3,801.74 | 3% 26.71K to 27.57K | (73%) |
| 25-Jun-19 10:19 AM View: | Hemispherx Biopharma, Inc. (AIM) | 21-Jun-19 | Market Purchase | 9,677 | $4.03 | $38,998.30 | 57% 17.03K to 26.71K | (71%) |
| 18-Jun-19 1:20 PM View: | Hemispherx Biopharma, Inc. (AIM) | 14-Jun-19 | Acquisition (other) | 711 | $5.35 | $3,803.85 | 4% 16.32K to 17.03K | (78%) |
| 14-Jun-19 2:06 PM View: | Hemispherx Biopharma, Inc. (AIM) | 03-Jun-19 | Acquisition (other) | 38,013 | $0.10 | $3,801.30 | 11% 340.08K to 378.1K | (73%) |
| 14-Jun-19 2:06 PM View: | Hemispherx Biopharma, Inc. (AIM) | 16-May-19 | Acquisition (other) | 25,342 | $0.15 | $3,801.30 | 8% 314.74K to 340.08K | (80%) |
| 17-Jun-19 4:48 PM View: | Hemispherx Biopharma, Inc. (AIM) | 08-May-19 | Conversion | 200,000 | -- | -- | 39% 518.1K to 718.1K | |
| 14-Jun-19 2:06 PM View: | Hemispherx Biopharma, Inc. (AIM) | 06-May-19 | Acquisition (other) | 18,101 | $0.21 | $3,801.21 | 6% 296.64K to 314.74K | |
| 14-Jun-19 2:06 PM View: | Hemispherx Biopharma, Inc. (AIM) | 03-May-19 | Acquisition (other) | 27,152 | $0.14 | $3,801.28 | 10% 269.49K to 296.64K | |
| 17-Jun-19 4:48 PM View: | Hemispherx Biopharma, Inc. (AIM) | 25-Mar-19 | Conversion | 140,000 | -- | -- | 37% 378.1K to 518.1K | |
| 13-Mar-19 2:34 PM View: | Hemispherx Biopharma, Inc. (AIM) | 28-Feb-19 | Exercise (in-the money or at-the-money) | 200,040 | -- | -- | 100% 0 to 200.04K | |
| 29-Nov-18 11:27 AM View: | Hemispherx Biopharma, Inc. (AIM) | 27-Nov-18 | Grant | 2,500 | -- | -- | < 1% 266.99K to 269.49K | |
| 06-Nov-18 11:24 AM View: | Hemispherx Biopharma, Inc. (AIM) | 05-Nov-18 | Market Purchase | 25,238 | $0.22 | $5,552.36 | 10% 241.75K to 266.99K | (90%) |
| 24-Jul-18 9:24 AM View: | Hemispherx Biopharma, Inc. (AIM) | 24-Jul-18 | Market Purchase | 126,000 | $0.31 | $39,060.00 | 109% 115.75K to 241.75K | (92%) |
| 30-Apr-18 6:37 AM View: | Hemispherx Biopharma, Inc. (AIM) | 27-Apr-18 | Market Purchase | 100,000 | $0.32 | $32,000.00 | 635% 15.75K to 115.75K | (91%) |
| 31-Mar-17 2:43 PM View: | Hemispherx Biopharma, Inc. (AIM) | 24-Aug-16 | Purchase | 15,750 | $2.21 | $34,807.50 | 100% 0 to 15.75K |